Not every patient with multiple sclerosis should be treated at time of diagnosis.
Pittock
Sean J
SJ
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Weinshenker
Brian G
BG
Noseworthy
John H
JH
Lucchinetti
Claudia F
CF
Keegan
Mark
M
Wingerchuk
Dean M
DM
Carter
Jonathan
J
Shuster
Elizabeth
E
Rodriguez
Moses
M
D002985:Clinical Protocols / Q000592:standards*; D004185:Disability Evaluation; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects / Q000276:immunology; D008279:Magnetic Resonance Imaging / Q000592:standards; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000628:therapy*; D018579:Patient Selection; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016899:Interferon-beta; D000068556:Interferon beta-1a